trending Market Intelligence /marketintelligence/en/news-insights/trending/22ofko0mt-s31yrxqvhxqg2 content esgSubNav
In This List

Elanix Biotechnologies appoints COO/CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Elanix Biotechnologies appoints COO/CFO

Germany's Elanix Biotechnologies AG appointed Egon Minar as CFO and COO, effective May 29.

Minar has previously served as CEO at Hamburg-based Navigon AG and Nuremberg-based AEG GmbH/Electrolux GmbH.